Targeted Disease(s):
Pulmonary Fibrosis
Purpose of Study:
TreatmentStudy Dates:
October 5, 2022 - November 23, 2024
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Nationwide
Funding Source:
Boehringer Ingelheim
Sponsors:
Boehringer IngelheimContact:
Phone: 1-800-243-0127Email: [email protected]
ClinicalTrails.gov Identifier:
NCT05321082